Zobrazeno 1 - 10
of 172
pro vyhledávání: '"L. A. Bolotina"'
Autor:
N. A. Avxentyev, I. I. Andreyashkina, E. V. Artamonova, L. V. Bolotina, E. I. Kovalenko, N. N. Sisigina
Publikováno v:
Опухоли женской репродуктивной системы, Vol 20, Iss 1, Pp 64-81 (2024)
At present, cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors such as palbociclib, ribociclib, and abemaciclib are widely used for the first-line treatment of locally advanced or metastatic breast cancer. However, direct comparisons of these treatm
Externí odkaz:
https://doaj.org/article/7c741cff50634683809ceae6e0a09add
Autor:
N. S. Sergeeva, T. A. Karmakova, V. V. Savchina, T. I. Deshkina, E. Yu. Karpenko, L. V. Bolotina, I. I. Alentov, N. V. Marshutina, A. A. Fedenko
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 4, Pp 44-54 (2023)
Platinum is the main component of the most chemotherapy (CT) regimens, but their use may be limited because of nephrotoxicity. Kidney injury molecule 1 (KIM-1) is considered as an early marker of cisplatininduced acute kidney injury (AKI). The aim of
Externí odkaz:
https://doaj.org/article/fb4d054817e74b32b8619e069c92407c
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 10, Iss 3, Pp 32-42 (2023)
Purpose. Evaluation of the effect of smoking on the immediate effectiveness (achievement of objective response – OR) of induction chemotherapy in patients receiving combined treatment for locally advanced HPV-positive squamous cell carcinoma of t
Externí odkaz:
https://doaj.org/article/62fe4f003b864c28b1f6409432c07a37
Publikováno v:
Сибирский онкологический журнал, Vol 22, Iss 2, Pp 26-33 (2023)
Given the favorable prognosis associated with HPV-positive oropharyngeal cancer, cancer care professionals are actively discussing the feasibility of de-escalating treatment strategy for this cohort of patients.The purpose of the study was to improve
Externí odkaz:
https://doaj.org/article/ac1d2f1dfc6144ef9b51e377dbfe3812
Autor:
T. I. Dеshkina, L. V. Bolotina, A. R. Gevorkov, A. V. Boyko, A. L. Kornietskaya, A. P. Polyakov, P. V. Golubev, R. S. Sydykova, A. A. Fedenko
Publikováno v:
Опухоли головы и шеи, Vol 12, Iss 4, Pp 10-16 (2023)
Introduction. About 600 new cases of malignant neoplasms of the paranasal sinuses and nasal cavity are detected annually in Russia. To date, there are no randomized trials to determine the optimal treatment algorithm for this group of patients. Data
Externí odkaz:
https://doaj.org/article/33c5fa7fbba3464c9dc8c5b10028eaff
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 164-170 (2022)
Brain metastases (BM) are associated with poor prognosis, short overall survival, and severely compromised quality of life in patients with advanced breast cancer (BC). BM create therapeutic challenges in BC due to the difficulty for the majority of
Externí odkaz:
https://doaj.org/article/0902f1e5726d4980a90709d882ba4b1e
Autor:
L. V. Bolotina, A. L. Kornietskaya, A. A. Kachmazov, N. S. Prizova, A. A. Paichadze, T. V. Ustinova, T. I. Deshkina, S. F. Evdokimova
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 179-184 (2022)
Hereditary breast cancer (BC) accounts for about 5-10% of cases. BRCA-associated tumors have been identified as a separate group of malignant neoplasms with distinctive clinical manifestations and specific treatment features. Understanding of biologi
Externí odkaz:
https://doaj.org/article/eb29d7aee9514c7e82e7f35e8cd03be6
Autor:
L. V. Bolotina, T. V. Ustinova, T. I. Dеshkina, P. V. Golubev, N. N. Lyubavina, A. A. Fedenko, A. D. Kaprin
Publikováno v:
Опухоли головы и шеи, Vol 12, Iss 1, Pp 35-52 (2022)
This article discusses current approaches to first-line chemotherapy for non-resectable head and neck squamous cell carcinoma and describes factors affecting the choice of treatment regimen according to the results of randomized clinical trials. We p
Externí odkaz:
https://doaj.org/article/7ef5a787f1684a399160ab6d43dca91e
Autor:
A. P. Polyakov, L. V. Bolotina, A. L. Kornietskaya, D. S. Kudashkina, D. V. Sidorov, A. A. Troitskiy, A. R. Gevorkov
Publikováno v:
Опухоли головы и шеи, Vol 12, Iss 1, Pp 114-119 (2022)
Cutaneous melanoma is characterized by an aggressive course associated with a tendency to metastasis. For a long time, the prognosis of patients with metastatic melanoma remained extremely poor. However, the introduction of immunooncological drugs in
Externí odkaz:
https://doaj.org/article/ea24c848bd484110b4f97cd901fa2716
Autor:
M. Yu. Fedyanin, L. Yu. Vladimirova, V. A. Chubenko, L. A. Zagorskaya, A. V. Belyaeva, O. L. Fakhrutdinova, S. A. Belukhin, A. S. Zhabina, L. V. Khalikova, L. V. Bolotina, R. V. Orlova, F. V. Moiseenko, G. Z. Mukhametshina, A. I. Khasanova, A. V. Belonogov, Kh. S. Musaeva, O. Yu. Novikova, I. Yu. Stradaeva, I. L. Popova, S. P. Erdniev, A. K. Ivanova, A. V. Androsova, P. S. Feoktistova, E. S. Kuzmina, E. V. Karabina, O. V. Nekrasova, O. V. Sekhina, A. A. Mishchenko, L. A. Mukova, B. Kh. Kertiev, G. I. Kosar, S. N. Osodoeva, A. I. Kats, R. R. Malina, M. A. Lyadova, A. A. Tryakin, S. A. Tyulandin
Publikováno v:
Тазовая хирургия и онкология, Vol 11, Iss 3-4, Pp 11-17 (2022)
Objective: to compare the efficacy and toxicity of aflibercept and bevacizumab in combination with fOLfIRI in secondline therapy for patients with metastatic colon cancer.Materials and methods. we performed a retrospective analysis of data on patient
Externí odkaz:
https://doaj.org/article/2d03f1018a45430f833cbda769ac5776